SCHEMBL7474635

SCHEMBL7474635

CCS(=O)(=O)N(CC(N)=O)C1CC(C)(C)Oc2ccc(F)cc21

nearest known ligand 0.48

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
KCNE1 P15382 3/20 0.48
KCNQ1 P51787 3/20 0.48
TRPV1 Q8NER1 15/20 0.42
AKR1B1 P15121 1/20 0.36
CYP3A4 P08684 1/20 0.36
CFTR P13569 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7468526 0.91 KCNE1 (0.49) KCNE1KCNQ1TRPV1AKR1B1CYP3A4
SCHEMBL7473039 0.90 KCNE1 (0.47) KCNE1KCNQ1TRPV1AKR1B1CYP3A4
SCHEMBL7472489 0.90 KCNE1 (0.48) KCNE1KCNQ1TRPV1AKR1B1CYP3A4
SCHEMBL6559266 0.88 KCNE1 (0.52) KCNE1KCNQ1TRPV1AKR1B1CYP3A4
SCHEMBL7479633 0.88 KCNE1 (0.43) KCNE1KCNQ1TRPV1AKR1B1CYP3A4
SCHEMBL6559324 0.87 KCNE1 (0.46) KCNE1KCNQ1TRPV1AKR1B1CYP3A4
SCHEMBL6558684 0.85 KCNE1 (0.45) KCNE1KCNQ1TRPV1AKR1B1CYP3A4
SCHEMBL6558722 0.84 KCNE1 (0.48) KCNE1KCNQ1TRPV1AKR1B1CYP3A4
SCHEMBL4621983 0.83 KCNE1 (0.45) KCNE1KCNQ1TRPV1CYP3A4
SCHEMBL14256398 0.83 KCNE1 (0.45) KCNE1KCNQ1TRPV1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0905131-B1 Sulfonamid-substituted chromans, process for their preparation, their use as medicine, and pharmaceutical preparation containing them AVENTIS PHARMA GMBH (DE) 2002-04-10 EP disclosed
US-5955607-A TREATING CARDIOVASCULAR AND GASTROINTESTINAL DISORDERS HOECHST MARION ROUSSEL DEUTSCHLAND (DE) 1999-09-21 US disclosed
EP-0905131-A1 Sulfonamid-substituted chromans, process for their preparation, their use as medicine, and pharmaceutical preparation containing them Hoechst Marion Roussel Deutschland GmbH (DE) 1999-03-31 EP disclosed